Research status and prospects of probiotics in functional gastrointestinal disorders in infants and toddlers

PAN Yun-Feng; WU Min-Chan; LIN Qian

doi:10.7499/j.issn.1008-8830.2401141

PDF(570 KB)

Chinese Journal of Contemporary Pediatrics ›› 2024, Vol. 26 ›› Issue (5) : 529-534. DOI: 10.7499/j.issn.1008-8830.2401141

REVIEW

Research status and prospects of probiotics in functional gastrointestinal disorders in infants and toddlers

PAN Yun-Feng, WU Min-Chan, LIN Qian

Author information +

History +

Abstract

Functional gastrointestinal disorders (FGIDs) are common digestive system diseases in children, which can severely affect the growth and development of infants and toddlers. Probiotics therapy, as a relatively safe treatment method, have attracted the attention of researchers. However, their effectiveness in treating FGIDs in infants and toddlers is still unclear. This article reviews the mechanisms of probiotics in treating FGIDs in infants and toddlers, explores the reasons for the inconsistency in various research results, and aims to provide assistance for the clinical treatment of FGIDs in infants and toddlers and future research.

Key words

Functional gastrointestinal disorder / Probiotics / Infant and toddler

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

PAN Yun-Feng, WU Min-Chan, LIN Qian. Research status and prospects of probiotics in functional gastrointestinal disorders in infants and toddlers[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(5): 529-534 https://doi.org/10.7499/j.issn.1008-8830.2401141

References

1 Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction[J]. Gastroenterology, 2016, 150(6): 1257-1261. PMID: 27147121. DOI: 10.1053/j.gastro.2016.03.035.
2 Velasco-Benítez CA, Collazos-Saa LI, García-Perdomo HA. Functional gastrointestinal disorders in neonates and toddlers according to the Rome IV criteria: a systematic review and meta-analysis[J]. Pediatr Gastroenterol Hepatol Nutr, 2022, 25(5): 376-386. PMID: 36148289. PMCID: PMC9482830. DOI: 10.5223/pghn.2022.25.5.376.
3 纪文静, 梁爱民, 曲成毅, 等. 中国7个城市婴幼儿常见胃肠道不适症状流行病学特征现况调查[J]. 中华流行病学杂志, 2018, 39(9): 1179-1183. PMID: 30293306. DOI: 10.3760/cma.j.issn.0254-6450.2018.09.007.
4 Black CJ, Drossman DA, Talley NJ, et al. Functional gastrointestinal disorders: advances in understanding and management[J]. Lancet, 2020, 396(10263): 1664-1674. PMID: 33049221. DOI: 10.1016/S0140-6736(20)32115-2.
5 中国中药协会儿童健康与药物研究专业委员会消化学组, 中华医学会儿科学分会消化学组, 中华儿科杂志编辑委员会. 婴幼儿功能性消化不良综合征诊断共识[J]. 中华儿科杂志, 2022, 60(7): 618-620. PMID: 35768346. DOI: 10.3760/cma.j.cn112140-20220129-00097.
6 Benninga MA, Nurko S, Faure C, et al. Childhood functional gastrointestinal disorders: neonate/toddler[J]. Gastroenterology, 2016, 150(6): 1443-1455.e2. PMID: 27144631. DOI: 10.1053/j.gastro.2016.02.016.
7 王长毅, 王猛, 江洪. 肠脑轴在高血压中的研究进展[J]. 中华老年心脑血管病杂志, 2022, 24(9): 994-996. DOI: 10.3969/j.issn.1009-0126.2022.09.026.
8 刘真真, 彭楠. 益生菌的应用现状和发展前景[J]. 微生物学报, 2023, 63(5): 1863-1887. DOI: 10.13343/j.cnki.wsxb.20230118.
9 邓紫薇, 仇成风, 王宏强, 等. 质子泵抑制剂治疗婴儿胃食管反流性疾病安全性的Meta分析[J]. 中国医院药学杂志, 2017, 37(10): 962-967. DOI: 10.13286/j.cnki.chinhosppharmacyj.2017.10.15.
10 Bell JC, Schneuer FJ, Harrison C, et al. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey[J]. Arch Dis Child, 2018, 103(7): 660-664. PMID: 29472195. DOI: 10.1136/archdischild-2017-314161.
11 Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease[J]. Gastroenterology, 2009, 136(6): 2003-2014. PMID: 19457424. DOI: 10.1053/j.gastro.2009.01.075.
12 D'Souza SM, Houston K, Keenan L, et al. Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: a paradigm shift from acid to bacteria?[J]. World J Gastroenterol, 2021, 27(18): 2054-2072. PMID: 34025064. PMCID: PMC8117736. DOI: 10.3748/wjg.v27.i18.2054.
13 Indrio F, Riezzo G, Raimondi F, et al. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns[J]. J Pediatr, 2008, 152(6): 801-806. PMID: 18492520. DOI: 10.1016/j.jpeds.2007.11.005.
14 Indrio F, Riezzo G, Raimondi F, et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants[J]. Eur J Clin Invest, 2011, 41(4): 417-422. PMID: 21114493. DOI: 10.1111/j.1365-2362.2010.02425.x.
15 Indrio F, Di Mauro A, Riezzo G, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial[J]. JAMA Pediatr, 2014, 168(3): 228-233. PMID: 24424513. DOI: 10.1001/jamapediatrics.2013.4367.
16 Indrio F, Riezzo G, Giordano P, et al. Effect of a partially hydrolysed whey infant formula supplemented with starch and Lactobacillus reuteri DSM 17938 on regurgitation and gastric motility[J]. Nutrients, 2017, 9(11): 1181. PMID: 29143799. PMCID: PMC5707653. DOI: 10.3390/nu9111181.
17 Dargenio VN, Cristofori F, Dargenio C, et al. Use of Limosilactobacillus reuteri DSM 17938 in paediatric gastrointestinal disorders: an updated review[J]. Benef Microbes, 2022, 13(3): 221-242. PMID: 35212258. DOI: 10.3920/BM2021.0151.
18 Baldassarre ME, Di Mauro A, Mastromarino P, et al. Administration of a multi-strain probiotic product to women in the perinatal period differentially affects the breast milk cytokine profile and may have beneficial effects on neonatal gastrointestinal functional symptoms. A randomized clinical trial[J]. Nutrients, 2016, 8(11): 677. PMID: 27801789. PMCID: PMC5133065. DOI: 10.3390/nu8110677.
19 Foster JP, Dahlen HG, Fijan S, et al. Probiotics for preventing and treating infant regurgitation: a systematic review and meta-analysis[J]. Matern Child Nutr, 2022, 18(1): e13290. PMID: 34908230. PMCID: PMC8710121. DOI: 10.1111/mcn.13290.
20 Wolke D, Bilgin A, Samara M. Systematic review and meta-analysis: fussing and crying durations and prevalence of colic in infants[J]. J Pediatr, 2017, 185: 55-61.e4. PMID: 28385295. DOI: 10.1016/j.jpeds.2017.02.020.
21 Zeevenhooven J, Browne PD, L'Hoir MP, et al. Infant colic: mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(8): 479-496. PMID: 29760502. DOI: 10.1038/s41575-018-0008-7.
22 Skonieczna-?ydecka K, Janda K, Kaczmarczyk M, et al. The effect of probiotics on symptoms, gut microbiota and inflammatory markers in infantile colic: a systematic review, meta-analysis and meta-regression of randomized controlled trials[J]. J Clin Med, 2020, 9(4): 999. PMID: 32252419. PMCID: PMC7231167. DOI: 10.3390/jcm9040999.
23 de Weerth C, Fuentes S, Puylaert P, et al. Intestinal microbiota of infants with colic: development and specific signatures[J]. Pediatrics, 2013, 131(2): e550-e558. PMID: 23319531. DOI: 10.1542/peds.2012-1449.
24 Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial[J]. J Pediatr, 2013, 162(2): 257-262. PMID: 22981952. DOI: 10.1016/j.jpeds.2012.08.004.
25 Sung V, Hiscock H, Tang ML, et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial[J]. BMJ, 2014, 348: g2107. PMID: 24690625. PMCID: PMC3972414. DOI: 10.1136/bmj.g2107.
26 Sung V, D'Amico F, Cabana MD, et al. Lactobacillus reuteri to treat infant colic: a meta-analysis[J]. Pediatrics, 2018, 141(1): e20171811. PMID: 29279326. DOI: 10.1542/peds.2017-1811.
27 P?rtty A, Lehtonen L, Kalliom?ki M, et al. Probiotic Lactobacillus rhamnosus GG therapy and microbiological programming in infantile colic: a randomized, controlled trial[J]. Pediatr Res, 2015, 78(4): 470-475. PMID: 26151493. DOI: 10.1038/pr.2015.127.
28 Kianifar H, Ahanchian H, Grover Z, et al. Synbiotic in the management of infantile colic: a randomised controlled trial[J]. J Paediatr Child Health, 2014, 50(10): 801-805. PMID: 24962875. DOI: 10.1111/jpc.12640.
29 Szajewska H, Berni Canani R, Domell?f M, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications[J]. J Pediatr Gastroenterol Nutr, 2023, 76(2): 232-247. PMID: 36219218. DOI: 10.1097/MPG.0000000000003633.
30 Fenton TR, Harries JT, Milla PJ. Disordered small intestinal motility: a rational basis for toddlers' diarrhoea[J]. Gut, 1983, 24(10): 897-903. PMID: 6618269. PMCID: PMC1420140. DOI: 10.1136/gut.24.10.897.
31 Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, et al. Aga technical review on the evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D)[J]. Gastroenterology, 2019, 157(3): 859-880. PMID: 31351880. DOI: 10.1053/j.gastro.2019.06.014.
32 Steutel NF, Zeevenhooven J, Scarpato E, et al. Prevalence of functional gastrointestinal disorders in European infants and toddlers[J]. J Pediatr, 2020, 221: 107-114. PMID: 32446468. DOI: 10.1016/j.jpeds.2020.02.076.
33 邹毅. 重庆地区儿科消化门诊功能性胃肠病的流行病学特征[D]. 重庆: 重庆医科大学, 2020.
34 黄俊杰. 西安市婴儿排便困难流行病学调查及其危险因素分析[D]. 西安: 空军军医大学, 2023.
35 王彩云. 婴儿功能性胃肠病流行病学及相关因素分析[D]. 福州: 福建医科大学, 2020.
36 王伟. 排便困难婴儿肠道菌群代谢改变的探讨[D]. 苏州: 苏州大学, 2020.
37 曾凡菲. 婴儿排便困难相关因素分析及其胎粪肠道菌群探究[D]. 广州: 南方医科大学, 2022.
38 Vernon-Roberts A, Alexander I, Day AS. Systematic review of pediatric functional gastrointestinal disorders (Rome IV criteria)[J]. J Clin Med, 2021, 10(21): 5087. PMID: 34768604. PMCID: PMC8585107. DOI: 10.3390/jcm10215087.
39 Lazarus G, Junaidi MC, Oswari H. Relationship of functional constipation and growth status: a systematic review and meta-analysis[J]. J Pediatr Gastroenterol Nutr, 2022, 75(6): 702-708. PMID: 36053122. DOI: 10.1097/MPG.0000000000003600.
40 胡根彪, 尹燕, 王红丽. 婴幼儿功能性便秘肠道菌群特征及影响因素Logistic回归分析[J]. 中国现代医生, 2019, 57(16): 54-57.
41 Yang L, Wang Y, Zhang Y, et al. Gut microbiota: a new avenue to reveal pathological mechanisms of constipation[J]. Appl Microbiol Biotechnol, 2022, 106(21): 6899-6913. PMID: 36190540. DOI: 10.1007/s00253-022-12197-2.
42 van Ginkel R, Reitsma JB, Büller HA, et al. Childhood constipation: longitudinal follow-up beyond puberty[J]. Gastroenterology, 2003, 125(2): 357-363. PMID: 12891536. DOI: 10.1016/s0016-5085(03)00888-6.
43 Zhang C, Jiang J, Tian F, et al. Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults[J]. Clin Nutr, 2020, 39(10): 2960-2969. PMID: 32005532. DOI: 10.1016/j.clnu.2020.01.005.
44 Lai H, Li Y, He Y, et al. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial[J]. Gut Microbes. 2023, 15(1): 2197837. PMID: 37078654. PMCID: PMC10120550. DOI: 10.1080/19490976.2023.2197837.
45 Wojtyniak K, Horvath A, Dziechciarz P, et al. Lactobacillus casei rhamnosus Lcr35 in the management of functional constipation in children: a randomized trial[J]. J Pediatr, 2017, 184: 101-105.e1. PMID: 28284477. DOI: 10.1016/j.jpeds.2017.01.068.
46 Bu LN, Chang MH, Ni YH, et al. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation[J]. Pediatr Int, 2007, 49(4): 485-490. PMID: 17587273. DOI: 10.1111/j.1442-200X.2007.02397.x.
47 Coccorullo P, Strisciuglio C, Martinelli M, et al. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study[J]. J Pediatr, 2010, 157(4): 598-602. PMID: 20542295. DOI: 10.1016/j.jpeds.2010.04.066.
48 Jung C, Kalach N, Degas V, et al. Effect of L. reuteri on bowel movements in children aged 6 months to 4 years: a double-blind randomized controlled trial[J]. Front Pediatr, 2022, 10: 997104. PMID: 36389355. PMCID: PMC9643683. DOI: 10.3389/fped.2022.997104.
49 Wojtyniak K, Szajewska H. Systematic review: probiotics for functional constipation in children[J]. Eur J Pediatr, 2017, 176(9): 1155-1162. PMID: 28762070. PMCID: PMC5563334. DOI: 10.1007/s00431-017-2972-2.
50 Suez J, Zmora N, Segal E, et al. The pros, cons, and many unknowns of probiotics[J]. Nat Med, 2019, 25(5): 716-729. PMID: 31061539. DOI: 10.1038/s41591-019-0439-x.